Bispecific antibody therapies have also received traction in 2025. This sort of targeted immunotherapy will work by binding at the same time to cancer cells and immune cells, encouraging the immune method mount a direct assault to the tumor. Medical TrialsĀ As part of our mission to get rid of most cancers, MD Anderson scientists conduct a huge